Price $0.24 |
Market Cap
52.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
4.0
|
P/B
2.08
|
P/S
0.63
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
5.2
|
Op. Cash Flow
10.7K
|
FCF
0.0
|
|
Op. Margin
9.70%
|
Net Margin
15.90%
|
ROE
61.60%
|
ROI
51.00%
|
|
ROA
19.30%
|
EPS Growth
157.20%
|
Current Ratio
1.3
|
Debt/Equity
0.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
